Design
Review
Authors
Loading...
P2Y12 remains a validated antithrombotic target; leaves open optimal selection of reversible versus irreversible antagonists in practice.
P2Y12 receptors are a highly specific and effective target for antithrombotic therapy, with both irreversible and reversible antagonists demonstrating clinical utility.
Kunapuli et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: